These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


330 related items for PubMed ID: 11054723

  • 21. Osteogenesis imperfecta and Paget's disease of bone. Biochemical and morphologic studies.
    Shapiro JR, Triche T, Rowe DW, Munabi A, Cattell HS, Schlesinger S.
    Arch Intern Med; 1983 Dec; 143(12):2250-7. PubMed ID: 6651417
    [Abstract] [Full Text] [Related]

  • 22. Fracture failure mechanisms in patients with osteogenesis imperfecta.
    Alman B, Frasca P.
    J Orthop Res; 1987 Dec; 5(1):139-43. PubMed ID: 3819906
    [Abstract] [Full Text] [Related]

  • 23. Mechanical properties of OI type III bone tissue measured by nanoindentation.
    Fan Z, Smith PA, Eckstein EC, Harris GF.
    J Biomed Mater Res A; 2006 Oct; 79(1):71-7. PubMed ID: 16758461
    [Abstract] [Full Text] [Related]

  • 24. Osteogenesis imperfecta at the beginning of bone and joint decade.
    Primorac D, Rowe DW, Mottes M, Barisić I, Anticević D, Mirandola S, Gomez Lira M, Kalajzić I, Kusec V, Glorieux FH.
    Croat Med J; 2001 Aug; 42(4):393-415. PubMed ID: 11471191
    [Abstract] [Full Text] [Related]

  • 25. Osteogenesis imperfecta: changes in noncollagenous proteins in bone.
    Vetter U, Fisher LW, Mintz KP, Kopp JB, Tuross N, Termine JD, Robey PG.
    J Bone Miner Res; 1991 May; 6(5):501-5. PubMed ID: 2068957
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P, Schott AM, Prockop D, Chevrel G.
    Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
    [Abstract] [Full Text] [Related]

  • 28. [The histo- and ultrastructural characteristics of the bone tissue in osteogenesis imperfecta].
    Osipenkova TK, Mikhaĭlova LN.
    Sud Med Ekspert; 1991 Mar; 34(1):18-24. PubMed ID: 1858111
    [Abstract] [Full Text] [Related]

  • 29. [Bone tissue in osteogenesis imperfecta: light and electron microscopic studies].
    Osipenkova-Vichtomova TK.
    Arkh Patol; 2006 Mar; 68(3):20-5. PubMed ID: 16830619
    [Abstract] [Full Text] [Related]

  • 30. Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants.
    Cheung MS, Arponen H, Roughley P, Azouz ME, Glorieux FH, Waltimo-Sirén J, Rauch F.
    J Bone Miner Res; 2011 Feb; 26(2):405-13. PubMed ID: 20721936
    [Abstract] [Full Text] [Related]

  • 31. Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV.
    Ward LM, Lalic L, Roughley PJ, Glorieux FH.
    Hum Mutat; 2001 May; 17(5):434. PubMed ID: 11317364
    [Abstract] [Full Text] [Related]

  • 32. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H.
    Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
    [Abstract] [Full Text] [Related]

  • 33. Intravenous pamidronate in osteogenesis imperfecta type VII.
    Cheung MS, Glorieux FH, Rauch F.
    Calcif Tissue Int; 2009 Mar; 84(3):203-9. PubMed ID: 19137231
    [Abstract] [Full Text] [Related]

  • 34. A morphometric analysis of osteoid collagen fibril diameter in osteogenesis imperfecta.
    Cassella JP, Barber P, Catterall AC, Ali SY.
    Bone; 1994 Mar; 15(3):329-34. PubMed ID: 8068454
    [Abstract] [Full Text] [Related]

  • 35. Type V osteogenesis imperfecta: a new form of brittle bone disease.
    Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ.
    J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
    [Abstract] [Full Text] [Related]

  • 36. Increased intra-cortical porosity reduces bone stiffness and strength in pediatric patients with osteogenesis imperfecta.
    Vardakastani V, Saletti D, Skalli W, Marry P, Allain JM, Adam C.
    Bone; 2014 Dec; 69():61-7. PubMed ID: 25238898
    [Abstract] [Full Text] [Related]

  • 37. Classification of Osteogenesis Imperfecta revisited.
    Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM.
    Eur J Med Genet; 2010 Dec; 53(1):1-5. PubMed ID: 19878741
    [Abstract] [Full Text] [Related]

  • 38. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
    Cabral WA, Makareeva E, Letocha AD, Scribanu N, Fertala A, Steplewski A, Keene DR, Persikov AV, Leikin S, Marini JC.
    Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
    [Abstract] [Full Text] [Related]

  • 39. Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta.
    Fedarko NS, Moerike M, Brenner R, Robey PG, Vetter U.
    J Bone Miner Res; 1992 Aug; 7(8):921-30. PubMed ID: 1442206
    [Abstract] [Full Text] [Related]

  • 40. Biochemical analysis of callus tissue in osteogenesis imperfecta type IV. Evidence for transient overmodification in collagen types I and III.
    Brenner RE, Vetter U, Nerlich A, Wörsdorfer O, Teller WM, Müller PK.
    J Clin Invest; 1989 Sep; 84(3):915-21. PubMed ID: 2760218
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.